{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:59:31Z","timestamp":1781614771782,"version":"3.54.5"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Herzzentrum G\u00f6ttingen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cervical cancer is the fourth most common cancer entity in women worldwide. Currently, malignant lesions are clinically managed by surgery, conventional chemotherapy, and\/or radiotherapy. However, a significant fraction of patients with cervical cancer does not respond to such treatments, highlighting the need for personalized targeted therapies. Histone 2B monoubiquitination (H2Bub1) is an epigenetic marker catalyzed by the RNF20 and RNF40 heterodimeric E3 ligase complex and is strongly involved in the regulation of gene expression. Despite its well-established significance in various malignant diseases, the role of RNF20 and RNF40 in cervical cancer remains poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We investigated the role of RNF20 and RNF40 in cervical cancer cells by leveraging paraffin-embedded IHC staining on patient material, in vitro functional assays, in vivo CAM assays, flow cytometry, various microscopy-based techniques, ChIP-qPCR, as well as genome-wide transcriptome analysis from cell lines and publicly available datasets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We showed that high RNF20 and RNF40 levels correlate with cervical cancer cell aggressiveness and poor patient prognosis. In addition, pathway enrichment analyses identified that the RNF20\/RNF40\/H2Bub1-axis positively regulates the peroxisome function. Peroxisomes play a key role in lipid metabolism and the homeostasis of reactive oxygen species. Loss of RNF20 and RNF40 leads to downregulation of peroxisome-related genes such as\n                      <jats:italic>PRDX5<\/jats:italic>\n                      ,\n                      <jats:italic>PEX6<\/jats:italic>\n                      , and\n                      <jats:italic>PMVK<\/jats:italic>\n                      , and thus impaired peroxisomal biogenesis, ROS metabolism, and increased lipid peroxidation, ultimately resulting in ferroptotic programmed cell death induction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Together, our results indicate that interfering with RNF20 and RNF40 driven H2Bub1 and the peroxisome transcriptional program could provide a novel target for a therapeutic approach against aggressive cervical cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12964-025-02279-9","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T04:48:49Z","timestamp":1751345329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["RNF20\/RNF40 supports the aggressive behavior in cervical cancer by regulating a peroxisome-based anti-ferroptotic mechanism"],"prefix":"10.1186","volume":"23","author":[{"given":"Shaishavi","family":"Jansari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Blandau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Prokakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja Maria","family":"Na\u00dfl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"K\u00fcffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"M\u00f6bius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Dullin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Ramos-Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leona","family":"Sch\u00fc\u00fcrhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Schridde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Plessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin. A.","family":"Bast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian A.","family":"Gayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Thoms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Gallwas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Wegwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"2279_CR1","unstructured":"Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L et al. Lyon, France: International Agency for Research on Cancer. Available from: https:\/\/gco.iarc.who.int\/today, accessed [28 02 2024]. 2024. Global Cancer Observatory: Cancer Today."},{"issue":"S1","key":"2279_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/ijgo.13865","volume":"155","author":"N Bhatla","year":"2021","unstructured":"Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri: 2021 update. Int J Gynecol Obstet. 2021;155(S1):28\u201344.","journal-title":"Int J Gynecol Obstet"},{"key":"2279_CR3","doi-asserted-by":"crossref","unstructured":"McGee P. Vol. 12, Diversity and Equality in Health and Care. Cervical cancer. 2015:77\u201380.","DOI":"10.21767\/2049-5471.100029"},{"issue":"1","key":"2279_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.6004\/jnccn.2019.0001","volume":"17","author":"WJ Koh","year":"2019","unstructured":"Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, et al. Cervical cancer, version 3.2019. JNCCN J Natl Compr Cancer Netw. 2019;17(1):64\u201384.","journal-title":"JNCCN J Natl Compr Cancer Netw"},{"issue":"1","key":"2279_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ajog.2015.07.022","volume":"214","author":"KS Pfaendler","year":"2016","unstructured":"Pfaendler KS, Tewari KS. Changing paradigms in the systemic treatment of advanced cervical cancer. Am J Obstet Gynecol. 2016;214(1):22\u201330.","journal-title":"Am J Obstet Gynecol"},{"issue":"9376","key":"2279_CR6","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/S0140-6736(03)13778-6","volume":"361","author":"SE Waggoner","year":"2003","unstructured":"Waggoner SE. Cervical cancer. Lancet. 2003;361(9376):2217\u201325.","journal-title":"Lancet"},{"key":"2279_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tvr.2022.200238","volume":"13","author":"CA Burmeister","year":"2022","unstructured":"Burmeister CA, Khan SF, Sch\u00e4fer G, Mbatani N, Adams T, Moodley J, et al. Cervical cancer therapies: current challenges and future perspectives. Tumour Virus Res. 2022;13:1\u201314.","journal-title":"Tumour Virus Res"},{"issue":"6","key":"2279_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11912-005-0007-z","volume":"7","author":"KS Tewari","year":"2005","unstructured":"Tewari KS, Monk BJ. Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer. Curr Oncol Rep. 2005;7(6):419\u201334.","journal-title":"Curr Oncol Rep"},{"issue":"5","key":"2279_CR9","doi-asserted-by":"publisher","first-page":"6868","DOI":"10.1002\/jcb.28007","volume":"120","author":"S Ebrahimi","year":"2019","unstructured":"Ebrahimi S, Soltani A, Hashemy SI. Oxidative stress in cervical cancer pathogenesis and resistance to therapy. J Cell Biochem. 2019;120(5):6868\u201377.","journal-title":"J Cell Biochem"},{"issue":"1","key":"2279_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2217\/fvl.10.73","volume":"6","author":"VM Williams","year":"2011","unstructured":"Williams VM, Filippova M, Soto U, Duerksen-Hughes PJ. HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress. Future Virol. 2011;6(1):45\u201357.","journal-title":"Future Virol"},{"issue":"2","key":"2279_CR11","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3390\/v5020708","volume":"5","author":"F De Marco","year":"2013","unstructured":"De Marco F. Oxidative stress and HPV carcinogenesis. Viruses. 2013;5(2):708\u201331.","journal-title":"Viruses"},{"key":"2279_CR12","doi-asserted-by":"crossref","unstructured":"Kajarabille N, Latunde-Dada GO. Programmed cell-death by ferroptosis: antioxidants as mitigators. Int J Mol Sci. 2019;20(19).","DOI":"10.3390\/ijms20194968"},{"issue":"7664","key":"2279_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547(7664):453\u20137.","journal-title":"Nature"},{"key":"2279_CR14","doi-asserted-by":"crossref","unstructured":"Wang C, Zeng J, Li LJ, Xue M, He SL. Cdc25A inhibits autophagy-mediated ferroptosis by upregulating ErbB2 through PKM2 dephosphorylation in cervical cancer cells. Cell Death Dis. 2021;12(11).","DOI":"10.1038\/s41419-021-04342-y"},{"issue":"14","key":"2279_CR15","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185(14):2401\u201321.","journal-title":"Cell"},{"key":"2279_CR16","doi-asserted-by":"crossref","unstructured":"Pratama AM, Sharma M, Naidu S, B\u00f6mmel H, Prabhuswamimath SC, Madhusudhan T et al. Peroxisomes and ppars: emerging role as master regulators of cancer metabolism. Mol Metab. 2024;90.","DOI":"10.1016\/j.molmet.2024.102044"},{"issue":"10","key":"2279_CR17","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1038\/s41418-021-00859-z","volume":"28","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Organelle-specific regulation of ferroptosis. Cell Death Differ. 2021;28(10):2843\u201356.","journal-title":"Cell Death Differ"},{"issue":"1","key":"2279_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s12964-024-01862-w","volume":"22","author":"J Han","year":"2024","unstructured":"Han J, Zheng D, Liu PS, Wang S, Xie X. Peroxisomal homeostasis in metabolic diseases and its implication in ferroptosis. Cell Commun Signal. 2024;22(1):475.","journal-title":"Cell Commun Signal"},{"issue":"8","key":"2279_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrg.2016.59","volume":"17","author":"CD Allis","year":"2016","unstructured":"Allis CD, Jenuwein T. The molecular hallmarks of epigenetic control. Nat Rev Genet. 2016;17(8):487\u2013500.","journal-title":"Nat Rev Genet"},{"issue":"9","key":"2279_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a025064","volume":"7","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Garcia BA. Comprehensive catalog of currently documented histone modifications. Cold Spring Harb Perspect Biol. 2015;7(9):1\u201320.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2279_CR21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cr.2011.22","volume":"21","author":"AJ Bannister","year":"2011","unstructured":"Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21:381\u201395.","journal-title":"Cell Res"},{"issue":"1","key":"2279_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrg2206","volume":"9","author":"S Henikoff","year":"2008","unstructured":"Henikoff S. Nucleosome destabilization in the epigenetic regulation of gene expression. Nat Rev Genet. 2008;9(1):15\u201326.","journal-title":"Nat Rev Genet"},{"issue":"4","key":"2279_CR23","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.cell.2007.01.030","volume":"128","author":"A Groth","year":"2007","unstructured":"Groth A, Rocha W, Verreault A, Almouzni G. Chromatin challenges during DNA replication and repair. Cell. 2007;128(4):721\u201333.","journal-title":"Cell"},{"issue":"9","key":"2279_CR24","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.dnarep.2009.04.010","volume":"8","author":"T Schleker","year":"2009","unstructured":"Schleker T, Nagai S, Gasser SM. Posttranslational modifications of repair factors and histones in the cellular response to stalled replication forks. DNA Repair (Amst). 2009;8(9):1089\u2013100.","journal-title":"DNA Repair (Amst)"},{"issue":"9","key":"2279_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a019505","volume":"8","author":"SB Baylin","year":"2016","unstructured":"Baylin SB, Jones PA. Epigenetic determinants of cancer. Cold Spring Harb Perspect Biol. 2016;8(9):1\u201335.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"4","key":"2279_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a019521","volume":"8","author":"JE Audia","year":"2016","unstructured":"Audia JE, Campbell RM. Histone modifications and cancer. Cold Spring Harb Perspect Biol. 2016;8(4):1\u201331.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"2279_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cell.2013.03.008","volume":"153","author":"H Shen","year":"2013","unstructured":"Shen H, Laird PW. Interplay between the cancer genome and epigenome. Cell. 2013;153(1):38\u201355.","journal-title":"Cell"},{"issue":"2","key":"2279_CR28","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41556-018-0258-1","volume":"21","author":"AM Valencia","year":"2019","unstructured":"Valencia AM, Kadoch C. Chromatin regulatory mechanisms and therapeutic opportunities in cancer. Nat Cell Biol. 2019;21(2):152\u201361.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"2279_CR29","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.molcel.2005.09.025","volume":"20","author":"B Zhu","year":"2005","unstructured":"Zhu B, Zheng Y, Pham AD, Mandal SS, Erdjument-Bromage H, Tempst P, et al. Monoubiquitination of human histone H2B: the factors involved and their roles in HOX gene regulation. Mol Cell. 2005;20(4):601\u201311.","journal-title":"Mol Cell"},{"issue":"1","key":"2279_CR30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S1097-2765(02)00826-2","volume":"11","author":"WW Hwang","year":"2003","unstructured":"Hwang WW, Venkatasubrahmanyam S, Ianculescu AG, Tong A, Boone C, Madhani HD. A conserved RING finger protein required for histone H2B monoubiquitination and cell size control. Mol Cell. 2003;11(1):261\u20136.","journal-title":"Mol Cell"},{"issue":"5","key":"2279_CR31","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.molcel.2019.03.029","volume":"74","author":"MI Valencia-S\u00e1nchez","year":"2019","unstructured":"Valencia-S\u00e1nchez MI, De Ioannes P, Wang M, Vasilyev N, Chen R, Nudler E, et al. Structural basis of Dot1L stimulation by histone H2B lysine 120 ubiquitination. Mol Cell. 2019;74(5):1010\u2013e10196.","journal-title":"Mol Cell"},{"key":"2279_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-017-1159-5","volume":"18","author":"W Xie","year":"2017","unstructured":"Xie W, Nagarajan S, Baumgart SJ, Kosinsky RL, Najafova Z, Kari V, et al. RNF40 regulates gene expression in an epigenetic context-dependent manner. Genome Biol. 2017;18:1\u201322.","journal-title":"Genome Biol"},{"key":"2279_CR33","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.semcancer.2021.12.007","volume":"86","author":"LM Jeusset","year":"2022","unstructured":"Jeusset LM, McManus KJ. Characterizing and exploiting the many roles of aberrant H2B monoubiquitination in cancer pathogenesis. Semin Cancer Biol. 2022;86:782\u201398.","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"2279_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/MCB.00488-18","volume":"39","author":"CC So","year":"2019","unstructured":"So CC, Ramachandran S, Martin A. E3 ubiquitin ligases RNF20 and RNF40 are required for Double-Stranded break (DSB) repair: evidence for monoubiquitination of histone H2B lysine 120 as a novel Axis of DSB signaling and repair. Mol Cell Biol. 2019;39(8):1\u201319.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"2279_CR35","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.molcel.2012.05.022","volume":"46","author":"O Karpiuk","year":"2012","unstructured":"Karpiuk O, Najafova Z, Kramer F, Hennion M, Galonska C, K\u00f6nig A, et al. The histone H2B monoubiquitination regulatory pathway is required for differentiation of multipotent stem cells. Mol Cell. 2012;46(5):705\u201313.","journal-title":"Mol Cell"},{"issue":"5","key":"2279_CR36","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.molcel.2012.05.023","volume":"46","author":"G Fuchs","year":"2012","unstructured":"Fuchs G, Shema E, Vesterman R, Kotler E, Wolchinsky Z, Wilder S, et al. RNF20 and USP44 regulate stem cell differentiation by modulating H2B monoubiquitylation. Mol Cell. 2012;46(5):662\u201373.","journal-title":"Mol Cell"},{"issue":"6","key":"2279_CR37","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.celrep.2016.01.020","volume":"14","author":"O Tarcic","year":"2016","unstructured":"Tarcic O, Pateras IS, Cooks T, Shema E, Kanterman J, Ashkenazi H, et al. RNF20 links histone H2B ubiquitylation with inflammation and inflammation-Associated Cancer. Cell Rep. 2016;14(6):1462\u201376.","journal-title":"Cell Rep"},{"issue":"11","key":"2279_CR38","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1038\/s41418-021-00808-w","volume":"28","author":"RL Kosinsky","year":"2021","unstructured":"Kosinsky RL, Zerche M, Kutschat AP, Nair A, Ye Z, Saul D, et al. RNF20 and RNF40 regulate vitamin D receptor-dependent signaling in inflammatory bowel disease. Cell Death Differ. 2021;28(11):3161\u201375.","journal-title":"Cell Death Differ"},{"issue":"4","key":"2279_CR39","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/ijc.30769","volume":"141","author":"K Zhang","year":"2017","unstructured":"Zhang K, Wang J, Tong TR, Wu X, Nelson R, Yuan YC, et al. Loss of H2B monoubiquitination is associated with poor-differentiation and enhanced malignancy of lung adenocarcinoma. Int J Cancer. 2017;141(4):766\u201377.","journal-title":"Int J Cancer"},{"issue":"4","key":"2279_CR40","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1158\/0008-5472.CAN-18-2297","volume":"79","author":"J Hooda","year":"2019","unstructured":"Hooda J, Novak M, Salomon MP, Matsuba C, Ramos RI, MacDuffie E, et al. Early loss of histone H2B monoubiquitylation alters chromatin accessibility and activates key immune pathways that facilitate progression of ovarian cancer. Cancer Res. 2019;79(4):760\u201372.","journal-title":"Cancer Res"},{"issue":"5","key":"2279_CR41","first-page":"2901","volume":"11","author":"X Zheng","year":"2018","unstructured":"Zheng X, Chen K, Liu X, Pan Y, Liu H. High RNF40 expression indicates poor prognosis of hepatocellular carcinoma. Int J Clin Exp Pathol. 2018;11(5):2901\u20136.","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"2279_CR42","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.1073\/pnas.1301045110","volume":"110","author":"E Wang","year":"2013","unstructured":"Wang E, Kawaoka S, Yu M, Shi J, Ni T, Yang W, et al. Histone H2B ubiquitin ligase RNF20 is required for MLL-rearranged leukemia. Proc Natl Acad Sci U S A. 2013;110(10):3901\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2279_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-03081-w","volume":"11","author":"F Wegwitz","year":"2020","unstructured":"Wegwitz F, Prokakis E, Pejkovska A, Kosinsky RL, Glatzel M, Pantel K, et al. The histone H2B ubiquitin ligase RNF40 is required for HER2-driven mammary tumorigenesis. Cell Death Dis. 2020;11(10):1\u201314.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2279_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-019-0698-x","volume":"11","author":"D Schneider","year":"2019","unstructured":"Schneider D, Chua RL, Molitor N, Hamdan FH, Rettenmeier EM, Prokakis E, et al. The E3 ubiquitin ligase RNF40 suppresses apoptosis in colorectal cancer cells. Clin Epigenetics. 2019;11(1):1\u201313.","journal-title":"Clin Epigenetics"},{"issue":"9","key":"2279_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-023-06157-5","volume":"14","author":"E Prokakis","year":"2023","unstructured":"Prokakis E, Jansari S, Boshnakovska A, Wiese M, Kusch K, Kramm C, et al. RNF40 epigenetically modulates Glycolysis to support the aggressiveness of basal-like breast cancer. Cell Death Dis. 2023;14(9):1\u201317.","journal-title":"Cell Death Dis"},{"issue":"2","key":"2279_CR46","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20(2):163\u201372.","journal-title":"Nat Immunol"},{"key":"2279_CR47","doi-asserted-by":"crossref","unstructured":"Wen Z, Luo D, Wang S, Rong R, Evers BM, Jia L et al. Deep Learning-Based H-Score quantification of Immunohistochemistry-Stained images. Mod Pathol. 2024;37(2).","DOI":"10.1016\/j.modpat.2023.100398"},{"issue":"23","key":"2279_CR48","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1038\/s41388-021-01814-5","volume":"40","author":"E Prokakis","year":"2021","unstructured":"Prokakis E, Dyas A, Gr\u00fcn R, Fritzsche S, Bedi U, Kazerouni ZB, et al. USP22 promotes HER2-driven mammary carcinoma aggressiveness by suppressing the unfolded protein response. Oncogene. 2021;40(23):4004\u201318.","journal-title":"Oncogene"},{"issue":"9","key":"2279_CR49","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/bioinformatics\/btp120","volume":"25","author":"C Trapnell","year":"2009","unstructured":"Trapnell C, Pachter L, Salzberg SL, TopHat. Discovering splice junctions with RNA-Seq. Bioinformatics. 2009;25(9):1105\u201311.","journal-title":"Bioinformatics"},{"issue":"12","key":"2279_CR50","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"key":"2279_CR51","doi-asserted-by":"crossref","unstructured":"Zu\u00f1iga Martinez M, de L, L\u00f3pez Mendoza CM, Tenorio Salazar J, Garc\u00eda Carranc\u00e1 AM, Cerb\u00f3n Cervantes MA, Alc\u00e1ntara-Quintana LE. Establishment, authenticity, and characterization of cervical cancer cell lines. Mol Cell Oncol. 2022;9(1).","DOI":"10.1080\/23723556.2022.2078628"},{"issue":"4","key":"2279_CR52","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nrc775","volume":"2","author":"JR Masters","year":"2002","unstructured":"Masters JR. HeLa cells 50 years on: the good, the bad and the ugly. Nat Rev Cancer. 2002;2(4):315\u20139.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"2279_CR53","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1016\/j.febslet.2012.04.002","volume":"586","author":"SA Johnsen","year":"2012","unstructured":"Johnsen SA. The enigmatic role of H2Bub1 in cancer. FEBS Lett. 2012;586(11):1592\u2013601.","journal-title":"FEBS Lett"},{"issue":"2","key":"2279_CR54","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.molmed.2019.09.012","volume":"26","author":"Y Sargsyan","year":"2020","unstructured":"Sargsyan Y, Thoms S. Staying in healthy contact: how peroxisomes interact with other cell organelles. Trends Mol Med. 2020;26(2):201\u201314.","journal-title":"Trends Mol Med"},{"issue":"1","key":"2279_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/oncsis.2015.49","volume":"5","author":"S Beloribi-Djefaflia","year":"2016","unstructured":"Beloribi-Djefaflia S, Vasseur S, Guillaumond F. Lipid metabolic reprogramming in cancer cells. Oncogenesis. 2016;5(1):1\u201310.","journal-title":"Oncogenesis"},{"issue":"7","key":"2279_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells9071692","volume":"9","author":"JA Kim","year":"2020","unstructured":"Kim JA. Peroxisome metabolism in cancer. Cells. 2020;9(7):1\u201319.","journal-title":"Cells"},{"issue":"6","key":"2279_CR57","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.jmb.2015.02.005","volume":"427","author":"PK Kim","year":"2015","unstructured":"Kim PK, Hettema EH. Multiple pathways for protein transport to peroxisomes. J Mol Biol. 2015;427(6):1176\u201390.","journal-title":"J Mol Biol"},{"issue":"13","key":"2279_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells11132067","volume":"11","author":"RM Judy","year":"2022","unstructured":"Judy RM, Sheedy CJ, Gardner BM. Insights into the structure and function of the Pex1\/Pex6 AAA-ATPase in peroxisome homeostasis. Cells. 2022;11(13):1\u201329.","journal-title":"Cells"},{"issue":"3","key":"2279_CR59","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.cmet.2014.01.002","volume":"19","author":"IJ Lodhi","year":"2014","unstructured":"Lodhi IJ, Semenkovich CF. Peroxisomes: A nexus for lipid metabolism and cellular signaling. Cell Metab. 2014;19(3):380\u201392.","journal-title":"Cell Metab"},{"issue":"12","key":"2279_CR60","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/s41589-019-0399-y","volume":"15","author":"Y Cao","year":"2019","unstructured":"Cao Y, Qiu T, Kathayat RS, Azizi SA, Thorne AK, Ahn D, et al. ABHD10 is an S-depalmitoylase affecting redox homeostasis through peroxiredoxin-5. Nat Chem Biol. 2019;15(12):1232\u201340.","journal-title":"Nat Chem Biol"},{"key":"2279_CR61","doi-asserted-by":"crossref","unstructured":"Henning U, M\u00f6slein EM, Lynen F. Biosynthesis of terpenes. V. Formation of 5-pyrophosphomevalonic acid by phosphomevalonic kinase. Volume 83. Archives of Biochemistry and Biophysics; 1959.","DOI":"10.1016\/0003-9861(59)90031-1"},{"issue":"12","key":"2279_CR62","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.bbamcr.2006.08.046","volume":"1763","author":"S Thoms","year":"2006","unstructured":"Thoms S, Erdmann R. Peroxisomal matrix protein receptor ubiquitination and recycling. Biochim Biophys Acta Mol Cell Res. 2006;1763(12):1620\u20138.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"10","key":"2279_CR63","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/ncb3230","volume":"17","author":"J Zhang","year":"2015","unstructured":"Zhang J, Tripathi DN, Jing J, Alexander A, Kim J, Powell RT, et al. ATM functions at the peroxisome to induce pexophagy in response to ROS. Nat Cell Biol. 2015;17(10):1259\u201369.","journal-title":"Nat Cell Biol"},{"issue":"21","key":"2279_CR64","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1080\/15384101.2017.1376149","volume":"16","author":"W Wang","year":"2017","unstructured":"Wang W, Subramani S. Role of PEX5 ubiquitination in maintaining peroxisome dynamics and homeostasis. Cell Cycle. 2017;16(21):2037\u201345.","journal-title":"Cell Cycle"},{"issue":"5","key":"2279_CR65","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"1","key":"2279_CR66","first-page":"1","volume":"24","author":"L Rochette","year":"2023","unstructured":"Rochette L, Dogon G, Rigal E, Zeller M, Cottin Y, Vergely C. Lipid peroxidation and Iron metabolism: two corner stones in the homeostasis control of ferroptosis. Int J Mol Sci. 2023;24(1):1\u201317.","journal-title":"Int J Mol Sci"},{"key":"2279_CR67","doi-asserted-by":"crossref","unstructured":"Farr\u00e9 J, Mahalingam SS, Proietto M, Subramani S. Peroxisome biogenesis, membrane contact sites, and quality control. EMBO Rep. 2019;20(1).","DOI":"10.15252\/embr.201846864"},{"issue":"3","key":"2279_CR68","first-page":"1","volume":"2014","author":"SJ Dixon","year":"2014","unstructured":"Dixon SJ, Patel D, Welsch M, Skouta R, Lee E, Hayano M, et al. Pharmacological Inhibition of cystine-glutamate exchange induces Endoplasmic reticulum stress and ferroptosis. Elife. 2014;2014(3):1\u201325.","journal-title":"Elife"},{"issue":"6","key":"2279_CR69","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.molcel.2014.04.013","volume":"54","author":"L Wu","year":"2014","unstructured":"Wu L, Li L, Zhou B, Qin Z, Dou Y. H2B ubiquitylation promotes RNA pol II processivity via PAF1 and pTEFb. Mol Cell. 2014;54(6):920\u201331.","journal-title":"Mol Cell"},{"issue":"5","key":"2279_CR70","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.molcel.2011.02.015","volume":"41","author":"L Moyal","year":"2011","unstructured":"Moyal L, Lerenthal Y, Gana-Weisz M, Mass G, So S, Wang SY, et al. Requirement of ATM-Dependent monoubiquitylation of histone H2B for timely repair of DNA Double-Strand breaks. Mol Cell. 2011;41(5):529\u201342.","journal-title":"Mol Cell"},{"issue":"5","key":"2279_CR71","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.molcel.2012.09.019","volume":"48","author":"KM Trujillo","year":"2012","unstructured":"Trujillo KM, Osley MA. A role for H2B ubiquitylation in DNA replication. Mol Cell. 2012;48(5):734\u201346.","journal-title":"Mol Cell"},{"issue":"8","key":"2279_CR72","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1158\/0008-5472.CAN-11-2209","volume":"72","author":"SB Chernikova","year":"2012","unstructured":"Chernikova SB, Razorenova OV, Higgins JP, Sishc BJ, Nicolau M, Dorth JA, et al. Deficiency in mammalian histone H2B ubiquitin ligase Bre1 (Rnf20\/Rnf40) leads to replication stress and chromosomal instability. Cancer Res. 2012;72(8):2111\u20139.","journal-title":"Cancer Res"},{"issue":"11","key":"2279_CR73","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1158\/2159-8290.CD-17-1018","volume":"8","author":"M Eckhardt","year":"2018","unstructured":"Eckhardt M, Zhang W, Gross AM, Von Dollen J, Johnson JR, Franks-Skiba KE, et al. Multiple routes to oncogenesis are promoted by the human papillomavirus\u2013host protein network. Cancer Discov. 2018;8(11):1474\u201389.","journal-title":"Cancer Discov"},{"key":"2279_CR74","doi-asserted-by":"crossref","unstructured":"Lee YJ. Knockout mouse models for Peroxiredoxins. Antioxidants. 2020;9(2).","DOI":"10.3390\/antiox9020182"},{"issue":"1","key":"2279_CR75","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3892\/ijo.2017.4013","volume":"51","author":"B Kim","year":"2017","unstructured":"Kim B, Kim YS, Ahn HM, Lee HJ, Jung MK, Jeong HY, et al. Peroxiredoxin 5 overexpression enhances tumorigenicity and correlates with poor prognosis in gastric cancer. Int J Oncol. 2017;51(1):298\u2013306.","journal-title":"Int J Oncol"},{"issue":"1","key":"2279_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-019-0493-5","volume":"18","author":"M Ellison","year":"2020","unstructured":"Ellison M, Mittal M, Chaudhuri M, Chaudhuri G, Misra S. The role of the redox\/miR-6855-3p\/PRDX5A axis in reversing SLUG-mediated BRCA2 Silencing in breast cancer cells. Cell Communication Signal. 2020;18(1):1\u201316.","journal-title":"Cell Communication Signal"},{"key":"2279_CR77","doi-asserted-by":"crossref","unstructured":"Ismail T, Kim Y, Lee H, Lee DS, Lee HS. Interplay between mitochondrial Peroxiredoxins and ROS in cancer development and progression. International Journal of Molecular Sciences. Volume 20. MDPI AG; 2019. pp. 1\u201323.","DOI":"10.3390\/ijms20184407"},{"issue":"4","key":"2279_CR78","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.21873\/anticanres.14949","volume":"41","author":"YZ Jin","year":"2021","unstructured":"Jin YZ, Gong YX, Liu Y, Xie DP, Ren CX, Lee SJ, et al. Peroxiredoxin V Silencing elevates susceptibility to doxorubicin-induced cell apoptosis via ROS-dependent mitochondrial dysfunction in AGS gastric cancer cells. Anticancer Res. 2021;41(4):1831\u201340.","journal-title":"Anticancer Res"},{"issue":"9","key":"2279_CR79","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.18632\/aging.204063","volume":"14","author":"HN Sun","year":"2022","unstructured":"Sun HN, Guo XY, Xie DP, Wang XM, Ren CX, Han YH, et al. Knockdown of Peroxiredoxin V increased the cytotoxicity of non-thermal plasma-treated culture medium to A549 cells. Aging. 2022;14(9):4000\u201313.","journal-title":"Aging"},{"issue":"3","key":"2279_CR80","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1080\/15548627.2021.1936932","volume":"18","author":"MS Dahabieh","year":"2022","unstructured":"Dahabieh MS, Huang F, Goncalves C, Flores Gonz\u00e1lez RE, Prabhu S, Bolt A, et al. Silencing PEX26 as an unconventional mode to kill drug-resistant cancer cells and forestall drug resistance. Autophagy. 2022;18(3):540\u201358.","journal-title":"Autophagy"},{"issue":"9","key":"2279_CR81","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1158\/1055-9965.EPI-17-0728","volume":"27","author":"BL Fridley","year":"2018","unstructured":"Fridley BL, Dai J, Raghavan R, Li Q, Winham SJ, Hou X, et al. Transcriptomic characterization of endometrioid, clear cell, and high-grade serous epithelial ovarian carcinoma. Cancer Epidemiol Biomarkers Prev. 2018;27(9):1101\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2279_CR82","doi-asserted-by":"crossref","unstructured":"Blicharz L, Czuwara J, Rudnicka L, Torrelo A. Autoinflammatory keratinization Diseases\u2014The concept, pathophysiology, and clinical implications. Clin Rev Allergy Immunol. 2023.","DOI":"10.1007\/s12016-023-08971-3"},{"key":"2279_CR83","doi-asserted-by":"crossref","unstructured":"Chen Z, Zhou X, Zhou X, Tang Y, Lu M, Zhao J et al. Phosphomevalonate kinase controls \u03b2-Catenin signaling via the metabolite 5-Diphosphomevalonate. Adv Sci. 2023;10(12).","DOI":"10.1002\/advs.202204909"},{"key":"2279_CR84","doi-asserted-by":"crossref","unstructured":"Luo Y, Huang S, Wei J, Zhou H, Wang W, Yang J et al. Long noncoding RNA LINC01606 protects colon cancer cells from ferroptotic cell death and promotes stemness by SCD1\u2013Wnt\/\u03b2-catenin\u2013TFE3 feedback loop signalling. Clin Transl Med. 2022;12(4).","DOI":"10.1002\/ctm2.752"},{"issue":"9","key":"2279_CR85","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1111\/cas.15896","volume":"114","author":"SS Park","year":"2023","unstructured":"Park SS, Kwon MR, Ju EJ, Shin SH, Park J, Ko EJ, et al. Targeting phosphomevalonate kinase enhances radiosensitivity via ubiquitination of the replication protein A1 in lung cancer cells. Cancer Sci. 2023;114(9):3583\u201394.","journal-title":"Cancer Sci"},{"issue":"1","key":"2279_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-23205-w","volume":"12","author":"A Aersilan","year":"2022","unstructured":"Aersilan A, Hashimoto N, Yamagata K, Yokoyama M, Nakayama A, Shi X, et al. MicroRNA-874 targets phosphomevalonate kinase and inhibits cancer cell growth via the mevalonate pathway. Sci Rep. 2022;12(1):1\u201319.","journal-title":"Sci Rep"},{"issue":"1","key":"2279_CR87","first-page":"1","volume":"5","author":"D Tang","year":"2020","unstructured":"Tang D, Kroemer G. Peroxisome: the new player in ferroptosis. Signal Transduct Target Ther. 2020;5(1):1\u20132.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"2279_CR88","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1038\/s41418-021-00769-0","volume":"28","author":"W Cui","year":"2021","unstructured":"Cui W, Liu D, Gu W, Chu B. Peroxisome-driven ether-linked phospholipids biosynthesis is essential for ferroptosis. Cell Death Differ. 2021;28(8):2536\u201351.","journal-title":"Cell Death Differ"},{"issue":"7826","key":"2279_CR89","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-020-2732-8","volume":"585","author":"Y Zou","year":"2020","unstructured":"Zou Y, Henry WS, Ricq EL, Graham ET, Phadnis VV, Maretich P, et al. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature. 2020;585(7826):603\u20138.","journal-title":"Nature"},{"key":"2279_CR90","first-page":"1","volume":"9","author":"X Chen","year":"2021","unstructured":"Chen X, Comish PB, Tang D, Kang R. Characteristics and biomarkers of ferroptosis. Front Cell Dev Biol. 2021;9:1\u20139.","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"2279_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/embr.201847563","volume":"20","author":"Y Wang","year":"2019","unstructured":"Wang Y, Yang L, Zhang X, Cui W, Liu Y, Sun Q, et al. Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53. EMBO Rep. 2019;20(7):1\u201316.","journal-title":"EMBO Rep"},{"issue":"1","key":"2279_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-020-01157-x","volume":"19","author":"Y Wu","year":"2020","unstructured":"Wu Y, Zhang S, Gong X, Tam S, Xiao D, Liu S, et al. The epigenetic regulators and metabolic changes in ferroptosis-Associated cancer progression. Mol Cancer. 2020;19(1):1\u201317.","journal-title":"Mol Cancer"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02279-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02279-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02279-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:47:00Z","timestamp":1781614020000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-025-02279-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2279"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02279-9","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"28 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"SJ: Immunofluorescence (IF) staining, in vitro functional assays; real-time PCR, western blot analysis, flow cytometry analysis, RNA-seq library preparation and analysis, ChIP-qPCR, CAM Assay, IHC imaging, Analysis of CT scans, figure design and conception, manuscript preparation and edition, project design and conception, revision and finalization. AB: PEX14 Immunofluorescence staining, in vitro functional assays, flow cytometry analysis. EP: IHC quantification, figure design and conception, project design and conception. DG: Single-cell sequencing analysis. AMN: Western Blots. SK: IHC stainings. WM: Electron Microscopy. CD: Micro-CT scans, FRG: STED Microscopy. L Sch\u00fc\u00fcrhuis, LF, L Schridde: Procurement of IHC patient samples. MP, ST: PMP70 IF staining, confocal microscopy, and peroxisome analysis. CB: in vitro functional assays, RNA-seq library preparation and analysis. FAG: Manuscript editing. JG: manuscript conception and edition, FW: project conception, manuscript edition, revision and finalization.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contribution"}},{"value":"TCGA patient data and IHC patient CC biopsy material were collected with their consent and approval by the local ethical authorities.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"304"}}